 | • レポートコード：MRC2204A212 • 出版社/出版日：Transparency Market Research / 2022年2月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、アメリカのASR・RUO市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品種類別分析、エンドユーザー別分析、競争状況などを掲載しています。 |
U.S. ASRs and RUOs Market – Scope of ReportTMR’s report on the ASRs and RUOs market in the U.S. studies the current as well as future prospects of the ASRs and RUOs market in the U.S. Stakeholders of the report include companies and intermediaries engaged in provision of ASRs and RUOs as well as new players planning to enter the market.
The report provides market value in terms of US$ Mn for the period from 2017 to 2031, along with the compound annual growth rate (CAGR %) from 2021 to 2031 are provided for all segments, considering 2020 as the base year and 2017–2019 as the historical years.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the ASRs and RUOs market in the U.S.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the ASRs and RUOs market in the U.S.
This report comprises an elaborate executive summary, along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the ASRs and RUOs market in the U.S. with respect to the leading market segments based on product type and end-user by application.
The ASRs and RUOs market in the U.S. has been studied based on major segments and their regional as well as national markets.
The report delves into the competition landscape of the ASRs and RUOs market in the U.S. Key players operating in the ASRs and RUOs market in the U.S. have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the ASRs and RUOs market in the U.S. profiled in this report.
Key Questions Answered in U.S. ASRs and RUOs Market Report
What is the sales/revenue generated by ASRs and RUOs suppliers/manufacturers across the U.S. during the forecast period?
What are the key trends in the ASRs and RUOs market in the U.S.?
What are the major drivers, restraints, opportunities, and threats in the market?
Which segment is set to expand at the fastest CAGR during the forecast period?
Which ASRs and RUOs segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?
U.S. ASRs and RUOs Market – Research Objectives and Research Approach
The comprehensive report on the ASRs and RUOs market in the U.S. begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the ASRs and RUOs market in the U.S. in terms of product type and end-user by application. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the ASRs and RUOs market in the U.S.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. ASRs and RUOs Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. ASRs and RUOs Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. General Purpose Reagents Uses in Lab-developed Tests: Overview
5.2. General Purpose Reagents Market: Federal Oversight of Diagnostic Tests
5.3. Porters Five Forces Model
5.4. Regulatory Scenario: U.S. ASRs and RUOs Market
5.5. COVID-19 Pandemic Impact on Industry
6. U.S. ASRs and RUOs Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Analyte Specific Reagents
6.3.2. Research Use Only Products
6.4. Market Attractiveness Analysis, By Product Type
7. U.S. ASRs and RUOs Market Analysis and Forecast, By End-user by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user by Application, 2017–2031
7.3.1. Human Healthcare
7.3.2. Veterinary
7.3.3. Environmental
7.3.4. Food Industry
7.3.5. Academic & Research Institutes
7.3.6. Others
7.4. Market Attractiveness Analysis, By End-user by Application
8. Competition Landscape
8.1. Competitive Business Strategies
8.2. Company Profiles
8.2.1. BioLegend, Inc.
8.2.1.1. Company Description
8.2.1.2. Business Overview
8.2.1.3. Financial Overview
8.2.1.4. Strategic Overview
8.2.1.5. SWOT Analysis
8.2.2. ELITechGroup
8.2.2.1. Company Description
8.2.2.2. Business Overview
8.2.2.3. Financial Overview
8.2.2.4. Strategic Overview
8.2.2.5. SWOT Analysis
8.2.3. BD
8.2.3.1. Company Description
8.2.3.2. Business Overview
8.2.3.3. Financial Overview
8.2.3.4. Strategic Overview
8.2.3.5. SWOT Analysis
8.2.4. bioMerieux, Inc.
8.2.4.1. Company Description
8.2.4.2. Business Overview
8.2.4.3. Financial Overview
8.2.4.4. Strategic Overview
8.2.4.5. SWOT Analysis
8.2.5. Genetic Signatures
8.2.5.1. Company Description
8.2.5.2. Business Overview
8.2.5.3. Financial Overview
8.2.5.4. Strategic Overview
8.2.5.5. SWOT Analysis
8.2.6. Thermo Fisher Scientific, Inc.
8.2.6.1. Company Description
8.2.6.2. Business Overview
8.2.6.3. Financial Overview
8.2.6.4. Strategic Overview
8.2.6.5. SWOT Analysis
8.2.7. Danaher Corporation
8.2.7.1. Company Description
8.2.7.2. Business Overview
8.2.7.3. Financial Overview
8.2.7.4. Strategic Overview
8.2.7.5. SWOT Analysis
8.2.8. DiaSorin Molecular LLC
8.2.8.1. Company Description
8.2.8.2. Business Overview
8.2.8.3. Financial Overview
8.2.8.4. Strategic Overview
8.2.8.5. SWOT Analysis
8.2.9. LGC Biosearch Technologies
8.2.9.1. Company Description
8.2.9.2. Business Overview
8.2.9.3. Financial Overview
8.2.9.4. Strategic Overview
8.2.9.5. SWOT Analysis
8.2.10. altona Diagnostics GmbH
8.2.10.1. Company Description
8.2.10.2. Business Overview
8.2.10.3. Financial Overview
8.2.10.4. Strategic Overview
8.2.10.5. SWOT Analysis
8.2.11. QIAGEN
8.2.11.1. Company Description
8.2.11.2. Business Overview
8.2.11.3. Financial Overview
8.2.11.4. Strategic Overview
8.2.11.5. SWOT Analysis
Table 01: General Purpose Reagents Market: Federal Oversight of Diagnostic Tests
Table 02: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 03: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by End-user by Application, 2017–2031
Table 04: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Human Healthcare, 2017–2031
Table 05: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Veterinary, 2017–2031
Table 06: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Environmental, 2017–2031
Table 07: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Food Industry, 2017–2031
Table 08: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Academic & Research Institutes, 2017–2031